Beranda › Atrofi Otot Tulang Belakang
Uji klinis Atrofi Otot Tulang Belakang yang merekrut di AS
23 studi untuk Atrofi Otot Tulang Belakang merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Mountain View, CA9 studi
- New York City, NY9 studi
- Philadelphia, PA7 studi
- Chicago, IL6 studi
- Norfolk, VA6 studi
- Grand Rapids, MI6 studi
- Boston, MA5 studi
- Houston, TX5 studi
- Lewisville, TX4 studi
- Little Rock, AR4 studi
- Phoenix, AZ4 studi
- Aurora, CO4 studi
- Memphis, TN3 studi
- Durham, NC3 studi
- Orlando, FL3 studi
- Cedar Rapids, IA3 studi
- Columbia, MO3 studi
- Harrisburg, PA3 studi
- Charlottesville, VA3 studi
- Minneapolis, MN3 studi
- Portland, OR3 studi
- Fort Worth, TX3 studi
- Dallas, TX3 studi
- Gainesville, FL3 studi
- Atlanta, GA3 studi
- Orange, CA3 studi
Berdasarkan negara bagian
- Arizona4 studi
- Arkansas4 studi
- California11 studi
- Colorado4 studi
- Florida8 studi
- Georgia3 studi
- Illinois6 studi
- Iowa3 studi
- Massachusetts6 studi
- Michigan6 studi
- Minnesota3 studi
- Missouri4 studi
- New York10 studi
- North Carolina3 studi
- Oregon3 studi
- Pennsylvania8 studi
- Tennessee3 studi
- Texas10 studi
- Virginia7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
Menerima pesertaFase 4
3 Months – 24 Months · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
Menerima pesertaFase 2
Hingga usia 2 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07047144A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
Menerima pesertaFase 3
Usia 15 hingga 60 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07444476A Registry of Cases of Spinal Muscular Atrophy
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07805278ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Menerima pesertaFase 4
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Menerima pesertaFase 2
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
Menerima pesertaFase 4
3 Months – 24 Months · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
Menerima pesertaFase 1
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06555419Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07521930Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Menerima peserta
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
Menerima pesertaFase 3
0 Days – 42 Days · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
Menerima pesertaFase 3
0 Days – 7 Months · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07444450Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
Menerima pesertaStudi observasional
Usia 5 hingga 20 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06532474Clinical Procedures to Support Research in ALS
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT03489278ALS/MND Natural History Study Data Repository
Menerima pesertaStudi observasional
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05966038Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT06955897Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06839469HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Menerima peserta
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT07488338Gait and Bone Health in SMA
Menerima pesertaStudi observasional
Usia 8 hingga 50 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT07400198Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07478172A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
Menerima pesertaStudi observasional
Usia 18 hingga 54 · Wanita · Diperbarui 9 Mar 2026 · NCT05789758Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT07223489Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 31 Jan 2025 · NCT04174157Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.